Pneumocystis primary infection in non-immunosuppressed infants in Lima, Peru

Theresa J Ochoa1, Beatriz Bustamante2, Coralith Garcia3

  • 1Instituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Perú; School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Perú.

Insights

Pneumocystis primary infection is common in Peruvian infants, particularly those aged 2-3 months during cooler seasons. Close living conditions increase the risk of Pneumocystis jirovecii transmission.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Epidemiology

Background:

  • Pneumocystis primary infection is a significant concern in infants.
  • Data on Pneumocystis infection in non-immunosuppressed infants is limited, especially in South America.

Purpose of the Study:

  • To investigate the prevalence and risk factors of Pneumocystis primary infection in healthy infants in Lima, Peru.
  • To provide original data on Pneumocystis jirovecii DNA detection in a well-baby population.

Main Methods:

  • A cross-sectional study enrolled 146 infants under seven months old from Lima, Peru.
  • Nasopharyngeal aspirates were analyzed for Pneumocystis jirovecii DNA using PCR.
  • Demographic and clinical data were collected to identify risk factors.

Main Results:

  • Pneumocystis jirovecii DNA was detected in 30.8% of infants, often without respiratory symptoms.
  • Infection was more frequent in younger infants (2-3 months) and during cooler seasons (winter/spring).
  • Living in crowded conditions (≤ 1 bedroom per household) was associated with higher detection rates (OR=3.03).

Conclusions:

  • Pneumocystis primary infection in this Peruvian cohort is most prevalent in 2-3-month-old infants.
  • Seasonal factors (winter/spring) and household crowding are associated with increased Pneumocystis detection.
  • Findings highlight the importance of early detection and potential transmission routes in infants.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
407
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.0K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.7K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
233
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
503
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
525